Blocking vascular endothelial growth factor with soluble Flt‐1 improves the chondrogenic potential of mouse skeletal muscle–derived stem cells
Open Access
- 30 December 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (1), 155-165
- https://doi.org/10.1002/art.24153
Abstract
Objective To investigate the effect of vascular endothelial growth factor (VEGF) stimulation and the effect of blocking VEGF with its antagonist, soluble Flt‐1 (sFlt‐1), on chondrogenesis, using muscle‐derived stem cells (MDSCs) isolated from mouse skeletal muscle. Methods The direct effect of VEGF on the in vitro chondrogenic ability of mouse MDSCs was tested using a pellet culture system, followed by real‐time quantitative polymerase chain reaction (PCR) and histologic analyses. Next, the effect of VEGF on chondrogenesis within the synovial joint was tested, using genetically engineered MDSCs implanted into rat osteochondral defects. In this model, MDSCs transduced with a retroviral vector to express bone morphogenetic protein 4 (BMP‐4) were coimplanted with MDSCs transduced to express either VEGF or sFlt‐1 (a VEGF antagonist) to provide a gain‐ and loss‐of‐function experimental design. Histologic scoring was used to compare cartilage formation among the treatment groups. Results Hyaline‐like cartilage matrix production was observed in both VEGF‐treated and VEGF‐blocked (sFlt‐1–treated) pellet cultures, but quantitative PCR revealed that sFlt‐1 treatment improved the expression of chondrogenic genes in MDSCs that were stimulated to undergo chondrogenic differentiation with BMP‐4 and transforming growth factor β3 (TGFβ3). In vivo testing of articular cartilage repair showed that VEGF‐transduced MDSCs caused an arthritic change in the knee joint, and sFlt‐1 improved the MDSC‐mediated repair of articular cartilage, compared with BMP‐4 alone. Conclusion Soluble Flt‐1 gene therapy improved the BMP‐4– and TGFβ3‐induced chondrogenic gene expression of MDSCs in vitro and improved the persistence of articular cartilage repair by preventing vascularization and bone invasion into the repaired articular cartilage.This publication has 38 references indexed in Scilit:
- Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cellsOsteoarthritis and Cartilage, 2007
- Synovial Stem Cells Are Regionally Specified According to Local Microenvironments After Implantation for Cartilage RegenerationThe International Journal of Cell Cloning, 2006
- Long-Term Self-Renewal of Postnatal Muscle-derived Stem CellsMolecular Biology of the Cell, 2005
- Synergistic enhancement of bone formation and healing by stem cell–expressed VEGF and bone morphogenetic protein-4JCI Insight, 2002
- Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defectMicroscopy Research and Technique, 2002
- Identification of a novel population of muscle stem cells in miceThe Journal of cell biology, 2002
- Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the kneeThe Journal of Bone and Joint Surgery. British volume, 2002
- Development and regulation of osteophyte formation during experimental osteoarthritisOsteoarthritis and Cartilage, 2002
- Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limbDevelopmental Dynamics, 2001
- Development of an MFG-Based Retroviral Vector System for Secretion of High Levels of Functionally Active Human BMP4Molecular Therapy, 2001